We are pleased to welcome Ellen Brunzell to Disruptive Pharma.
Ellen is a licensed pharmacist and recently completed her PhD in pharmaceutical physical chemistry at Uppsala University. Her research has focused on drug substances, formulation-relevant interactions and peptide aggregation, bringing valuable expertise to our work in pharmaceutical formulation and development.
Ellen first became familiar with the technology behind Formulite® during her pharmacy studies, making her new role at Disruptive Pharma a natural continuation of that early interest.
We are very happy to have Ellen join the team as we continue developing Formulite® for improved oral drug formulations.
Welcome, Ellen!